Home/Filings/4/0001250853-19-000091
4//SEC Filing

Orzechowski Frank 4

Accession 0001250853-19-000091

CIK 0000788611other

Filed

Jul 21, 8:00 PM ET

Accepted

Jul 22, 8:51 PM ET

Size

8.1 KB

Accession

0001250853-19-000091

Insider Transaction Report

Form 4
Period: 2019-07-18
Orzechowski Frank
CFO, PFO and PAO
Transactions
  • Award

    Stock Option (right to buy)

    2019-07-18+60,00060,000 total
    Exercise: $1.40Exp: 2024-06-30Common Stock (60,000 underlying)
  • Award

    Stock Option (right to buy)

    2019-07-18+2,5002,500 total
    Exercise: $1.40From: 2019-07-18Exp: 2024-06-30Common Stock (2,500 underlying)
Footnotes (2)
  • [F1]The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on July 18, 2019.
  • [F2]The stock option vests as follows: 3,872 shares will vest and become exercisable on July 1, 2020; 9,000 shares will vest and become exercisable on July 1, 2021; 14,128 shares will vest and become exercisable on July 1, 2022, and 33,000 shares will vest and become exercisable on July 1, 2023, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.

Issuer

SIGMA LABS, INC.

CIK 0000788611

Entity typeother

Related Parties

1
  • filerCIK 0001781860

Filing Metadata

Form type
4
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 8:51 PM ET
Size
8.1 KB